BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 25046978)

  • 1. Evaluation of myelodysplasia syndrome screening during routine hematological analysis on the ADVIA 2120i.
    Koenders MM; Taal PH; Kluiters-De Hingh Y; Van Wijk EM
    Int J Lab Hematol; 2015 Apr; 37(2):e38-9. PubMed ID: 25046978
    [No Abstract]   [Full Text] [Related]  

  • 2. Possibility of myelodysplastic syndromes screening using a complete blood automated cell count.
    Rocco V; Maconi M; Gioia M; Silvestri MG; Tanca D; Catalano T; Avino D; Di Palma A; Rovetti A; Danise P
    Leuk Res; 2011 Dec; 35(12):1623-7. PubMed ID: 21764450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Picking up myelodysplastic syndromes and megaloblastic anemias on peripheral blood: use of NEUT-X and NEUT-Y in guiding smear reviews.
    Goel S; Sachdev R; Gajendra S; Jha B; Sahni T; Dorwal P; Srivastava C; Tiwari AK; Sood N; Gupta S; Raina V; Vaid AK
    Int J Lab Hematol; 2015 Apr; 37(2):e48-51. PubMed ID: 25132616
    [No Abstract]   [Full Text] [Related]  

  • 4. [The clinicopathological evaluation of automated cytochemical hematology system (Technicon H1) in patients with leukemia and myelodysplastic syndrome].
    Koui F; Chiba T
    Rinsho Byori; 1992 Jun; 40(6):586-94. PubMed ID: 1513030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The technicon H6000 automated hematology analyzer in the diagnosis and classification of the myelodysplastic syndromes.
    Orazi A; Milanesi B
    Haematologica; 1990; 75(1):87-90. PubMed ID: 2338293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myelodysplastic syndrome: identification in the routine hematology laboratory.
    Rappaport ES; Helbert B; Ladd DJ; Trowbridge AA
    South Med J; 1987 Aug; 80(8):969-74. PubMed ID: 3616725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison study of the rates of manual peripheral blood smear review from 3 automated hematology analyzers, Unicel DxH 800, ADVIA 2120i, and XE 2100, using international consensus group guidelines.
    Kim SJ; Kim Y; Shin S; Song J; Choi JR
    Arch Pathol Lab Med; 2012 Nov; 136(11):1408-13. PubMed ID: 23106587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal flagging combinations for best performance of five blood cell analyzers.
    Depoorter M; Goletti S; Latinne D; Defour J
    Int J Lab Hematol; 2015 Feb; 37(1):63-70. PubMed ID: 24739185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 'Complete blood counts and automated leucocyte differential results obtained by Siemens ADVIA 2120i in 145 cases of acute leukaemia in adults: insights into cellular pathophysiology and differential diagnosis'.
    Canovi S; Campioli D
    Int J Lab Hematol; 2016 Dec; 38(6):e107-e110. PubMed ID: 27574115
    [No Abstract]   [Full Text] [Related]  

  • 10. Automated screening for myelodysplastic syndromes through analysis of complete blood count and cell population data parameters.
    Raess PW; van de Geijn GJ; Njo TL; Klop B; Sukhachev D; Wertheim G; McAleer T; Master SR; Bagg A
    Am J Hematol; 2014 Apr; 89(4):369-74. PubMed ID: 24276948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematological improvement during iron-chelation therapy in myelodysplastic syndromes: the experience of the "Rete Ematologica Lombarda".
    Molteni A; Riva M; Pellizzari A; Borin L; Freyrie A; Greco R; Ubezio M; Bernardi M; Fariciotti A; Nador G; Nichelatti M; Ravano E; Morra E
    Leuk Res; 2013 Oct; 37(10):1233-40. PubMed ID: 23906627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Myelodysplastic syndrome. Main symptoms: mostly nonspecific anemia symptoms].
    Kolyvanos Naumann U; Nigg C; Käser L; Vetter W
    Praxis (Bern 1994); 2005 Jul; 94(28-29):1095-100; quiz 1101. PubMed ID: 16078749
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative study of quantitative performances between the new Sysmex XN-L (XN-550) haematology analyser and the XN-9000 in a routine laboratory.
    Geara C; Cornet E; Troussard X
    Int J Lab Hematol; 2016 Feb; 38(1):e10-1. PubMed ID: 26508402
    [No Abstract]   [Full Text] [Related]  

  • 14. Myelodysplasia diagnosed during pregnancy with temporary haematological improvement after delivery.
    Gidiri M; Masson EA; Ali S; Freites J; Carter C; Lindow SW
    J Obstet Gynaecol; 2009 Oct; 29(7):665-7. PubMed ID: 19757280
    [No Abstract]   [Full Text] [Related]  

  • 15. [Establishment and evaluation of review criteria for ADVIA 120/2120 and different series of hematology analyzers].
    Xing Y; Wang JZ; Pu CW; Shang K; Yan ZL; Bai YZ; Yang WS; Li T; Zhang SM
    Zhonghua Yi Xue Za Zhi; 2010 Jun; 90(22):1526-30. PubMed ID: 20973232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mast cell count and morphology in the diagnosis of low-grade myelodysplastic syndromes.
    Schellings MW; Christianen K; de Wild P; Kuijper P
    J Clin Pathol; 2013 Dec; 66(12):1092-4. PubMed ID: 23850707
    [No Abstract]   [Full Text] [Related]  

  • 17. Spherocytosis preceding the development of myelodysplasia.
    Aleem A; Murray JA
    Clin Lab Haematol; 2001 Aug; 23(4):249-51. PubMed ID: 11683786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Theory and practice of counting blood cells with hemocytometer (author's transl)].
    Hino S
    Rinsho Ketsueki; 1978 Sep; 19(9):1171-8. PubMed ID: 362002
    [No Abstract]   [Full Text] [Related]  

  • 19. Stomatocytosis as a presenting symptom of myelodysplasia.
    Konstantopoulos K; Vassilopoulos G; Adamides S; Alexandrakis M; Zervas J
    Med Oncol Tumor Pharmacother; 1992; 9(4):213-4. PubMed ID: 1342067
    [No Abstract]   [Full Text] [Related]  

  • 20. Paracentric inversion of chromosome 12 in myelodysplasia.
    Gaur S; Shukla V
    Am J Hematol; 2005 Apr; 78(4):318-9. PubMed ID: 15795910
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.